JPRN-UMIN000016206
Recruiting
Phase 1
A phase I/II clinical trial of radical radiotherapy using proton for early breast cancer - A phase I/II clinical trial of radical radiotherapy using proton for early breast cancer
Fukui Prefectural Hospital0 sites20 target enrollmentJanuary 13, 2015
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Fukui Prefectural Hospital
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Severe complication 2\.Previous treatment 3\.Active double primary 4\.Tumor invasion to skin or chest wall 5\.Distance between tumor border to skin less than 1cm on MRI. 6\.Previous irradiation at tumor site 7\. Non invasive ductal carcinoma (pure DCIS) 8\. Medically, psychologically or other reason who are not suitable for candidate. 9\. History of connective tissue diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerbreast cancerJPRN-UMIN000029478QST Hospital, National Institutes for Quantum and Radiological Sciences and Technology30
Recruiting
Phase 1
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerBreast cancerD001943JPRN-jRCTs032180154Karasawa Kumiko30
Active, Not Recruiting
Phase 1
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancerBreast cancerD001943JPRN-jRCTs032180153Karasawa Kumiko20
Recruiting
Phase 1
Phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancerJPRN-UMIN000010848ational Institute of Radiological Sciences20
Active, Not Recruiting
Phase 1
A study to investigate the effect of addition of metformin to standard treatment in patients with inoperable stage III non-small cell lung cancer.EUCTR2017-004877-15-BEAntwerp University Hospital, Department Thoracic Oncology104